Quantitative structure–activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and hepatomegaly associated with increased DNA synthesis

The results of a quantitative structure-activity relationship (QSAR) study on a total of 14 steroids exhibiting induction of a CYP3A-associated activity and increase in liver weight/DNA synthesis is reported. It is found that different, but related, structural descriptors correlate with increase in ethylmorphine N-demethylase activity (r=0.92) and with the increase in liver weight (r=0.78) and DNA synthesis (r=0.78). Although there is a strong correlation between increase in liver weight and DNA content (r=0.999), neither of these correlated with ethylmorphine N-demethylase activity. These findings are discussed in the light of CYP3A induction, substrate specificity and inhibition; a proposed model of human CYP3A4 based on sequence homology with CYP102, a bacterial P450 of known crystal structure, demonstrates the possible mode of interaction between substrates and inhibitors within the putative active site.

[1]  K. Lindros,et al.  Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. , 1995, The Biochemical journal.

[2]  Ian A. Wilson,et al.  Molecular basis of crossreactivity and the limits of antibody–antigen complementarity , 1993, Nature.

[3]  I Morize,et al.  Refinement of the C222(1) crystal form of oxidized uteroglobin at 1.34 A resolution. , 1987, Journal of molecular biology.

[4]  J Deisenhofer,et al.  Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.

[5]  J. Pople,et al.  Approximate Self-Consistent Molecular Orbital Theory. I. Invariant Procedures , 1965 .

[6]  H. Yamazaki,et al.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.

[7]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[8]  J. Pascussi,et al.  The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor , 1998, Nature Medicine.

[9]  J. G. Vinter,et al.  Strategic approaches to drug design. I. An integrated software framework for molecular modelling , 1987, J. Comput. Aided Mol. Des..

[10]  C. Ioannides.  Cytochromes P450 Metabolic and Toxicological Aspects , 1996 .

[11]  D. Lewis,et al.  Cytochromes P450: structure, function and mechanism. , 1996 .

[12]  A. Okey.  Enzyme induction in the cytochrome P-450 system. , 1990, Pharmacology & therapeutics.

[13]  W. Bursch,et al.  Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. , 1988, Cancer research.

[14]  L. Corcos.  Phenobarbital and dexamethasone induce expression of cytochrome P-450 genes from subfamilies IIB, IIC, and IIIA in mouse liver. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[15]  Yoshihiro Kudo,et al.  Automatic log P estimation based on combined additive modeling methods , 1990, J. Comput. Aided Mol. Des..

[16]  T. Poulos,et al.  The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.

[17]  D. Lewis,et al.  In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies. , 1997, Biochemical pharmacology.

[18]  D. Amacher,et al.  Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes. , 1998, Toxicology letters.

[19]  P. Maurel,et al.  Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. , 1992, Molecular pharmacology.

[20]  D. Lewis,et al.  Molecular modelling of the rat peroxisome proliferator-activated receptor -α (rPPARα) by homology with the human retinoic acid X receptor α (hRXRα) and investigation of ligand binding interactions I: QSARs , 1998 .

[21]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[22]  D. Lewis,et al.  Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  M H Tarbit,et al.  Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[24]  R. Schulte‐Hermann,et al.  Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. , 1986, Cancer research.

[25]  D. Lewis.  Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3). , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[26]  M. Wright,et al.  Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein. , 1994, Biochemical and biophysical research communications.